In chondrosarcoma and intrahepatic cholangiocarcinoma, the R132C alteration in IDH1 is the most frequent mutation[6,8], while in angioimmunoblastic T-cell lymphoma mutations in IDH2 are predominant[9]. Here, IDH2 is linked to intrahepatic cholangiocarcinoma.